Veterinary Medicines

Kefavet® vet. 250 mg, film-coated tablet

Not authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Kefavet® vet. 250 mg, film-coated tablet
Kefavet vet 250 mg filmomhulde tabletten
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    263.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:
  • Blister, 28 tablets
  • Blister, 70 tablets
  • Blister, 140 tablets
  • Blister, 14 tablets
  • Blister, 20 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Orion Corporation
Marketing authorisation date:
Manufacturing sites for batch release:
  • Orion Corporation
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 106747
Date of authorisation status change:
Reference member state:
  • Sweden
Procedure number:
  • SE/V/0114/001

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 19/01/2022
Download